AMI Asset Management Corp Invests $1.09 Million in Stevanato Group S.p.A. (NYSE:STVN)

AMI Asset Management Corp acquired a new position in shares of Stevanato Group S.p.A. (NYSE:STVN) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 49,956 shares of the company’s stock, valued at approximately $1,089,000.

Several other institutional investors have also recently added to or reduced their stakes in STVN. Thrivent Financial for Lutherans acquired a new position in shares of Stevanato Group during the second quarter valued at $30,477,000. Pembroke Management LTD raised its stake in shares of Stevanato Group by 143.7% during the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock worth $21,023,000 after buying an additional 619,747 shares during the last quarter. Tri Locum Partners LP acquired a new position in Stevanato Group in the second quarter valued at approximately $10,370,000. Conestoga Capital Advisors LLC grew its holdings in Stevanato Group by 5.5% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock worth $153,518,000 after acquiring an additional 400,087 shares during the period. Finally, Fred Alger Management LLC raised its position in shares of Stevanato Group by 24.2% during the 3rd quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after acquiring an additional 208,830 shares during the last quarter.

Analyst Ratings Changes

STVN has been the subject of a number of recent analyst reports. Bank of America upped their price objective on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, Wolfe Research started coverage on shares of Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of €28.60 ($29.79).

Stevanato Group Trading Up 0.5 %

Shares of Stevanato Group stock opened at €23.02 ($23.98) on Tuesday. The stock has a market cap of $6.97 billion, a P/E ratio of 48.98, a P/E/G ratio of 7.91 and a beta of 0.56. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.25) and a 12-month high of €34.73 ($36.18). The business’s 50 day moving average is €21.33 and its 200-day moving average is €20.42.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. During the same quarter in the prior year, the business earned $0.16 EPS. The business’s revenue was up 2.4% compared to the same quarter last year. Equities research analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.